Barrett & Company, Inc. Abbott Laboratories Transaction History
Barrett & Company, Inc.
- $221 Billion
- Q2 2024
A detailed history of Barrett & Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Barrett & Company, Inc. holds 1,875 shares of ABT stock, worth $212,062. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,875
Previous 1,875
-0.0%
Holding current value
$212,062
Previous $213 Million
8.58%
% of portfolio
0.09%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,131Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.8 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.41 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.12 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.47 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $198B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...